The Manhasset Times, Friday, December 23, 2016
MT
51
COMMUNITY NEWS
Mothers learn beer history Feinstein doctors discover molecule
The cheese spread at a couples event held at Craft Beer Cellar in Port Washington on Nov. 19 The Mothers’ Group of Manhasset couples’ events allow members to bond over exciting new adventures. Mother’s Group members did just that during the first couples event of the year which was held at Craft Beer Cellar located in Port Washington on Nov. 19. Event Chairs, Theresa McCabe and Genie Paek-Chang worked hard to make this event a success. As part of the experience, couples learned about the history and style profiles of different beers and ciders. In addition, Jessica, of The Village Cheese Shop (located in Mattituck), educated members on how to pair various cheeses and meats with a variety beers. Once their brief lesson was completed, members mingled and enjoyed the different pairings. Genie Chang found the event to be quite a learning experience, saying that she “had no idea beer had so much variety (arguably more than wine) and that it also had specific flavors that can be brought out when paired with the right food.” Mrs. Chang was “so happy to see everyone relaxed and enjoying themselves before the holiday craze.” Theresa McCabe’s favorite takeaway from the night was learning how much history is behind the process of cheese making. Mrs. McCabe “loved learning exactly what makes a lager a lager and an IPA an IPA.” “There was lots of chatter between old
Attendees learn how to pair cheese and beer at Craft Beer Cellar in Port Washington on Nov. 19 and new friends. I’d say we all left with full and happy bellies.” exclaimed Chang. The MGM is a member-based organization that holds a number of regular events throughout the year. For more information about the Mothers’ Group of Manhasset, including membership, visit www.manhassetmothersgroup.com. All are welcome to join the MGM and participate in exciting couples’, ladies’, and children’s events throughout the school year.
Sisterhood hosts presentation WRJ Sisterhood of Temple Judea recently welcomed Lauren Chizner, who gave a presentation regarding Hatikvah, the Israeli national anthem. Chizner described the many permutations of the song and how it finally became the national anthem of Israel. Chizner described the history of Hatikvah. It was originally written as a nine-stanza poem in 1878 by a Polish poet, Naphtali Imber, and then set to music, possibly based on a Moldavian folk song. Today, only the first stanza is incorporated from the original poem. When the State of Israel was established in 1948, Hatikvah was unofficially proclaimed the national anthem and was officially sanctioned as the national anthem by the Israeli Knesset in November 2004. A former member of the Sonderkommando reports that the song was spontaneously sung
by Czech Jews in the entryway to the AuschwitzBirkenau gas chamber in 1944. While singing they were beaten by Waffen-SS guards. The British Mandate government briefly banned its performance in 1919 due to Arab antiZionist political activity. In a BBC recording from April 20, 1945, Jewish survivors of Bergen-Belsen joyously sang Hatikvah, five days after liberation. Over the years, Hatikvah has been sung by Jews in times of horror and joy – and even banned.
In a recently published study, scientists at The Feinstein Institute for Medical Research described their discovery of a molecule that could indicate how long the body is deprived of oxygen during cardiac arrest. In a study published in Biomarkers, scientists at The Feinstein Institute for Medical Research described their discovery of a molecule, which could indicate how long the body is deprived of oxygen during cardiac arrest. This discovery can potentially allow health care professionals to better understand if a patient will regain full brain function after cardiac arrest and how to best administer treatment. Cardiac arrest occurs when the heart completely stops, preventing blood and oxygen from pumping through the body. Cardiopulmonary resuscitation (CPR) and other forms of resuscitation are used to get the heart started again; however this doesn’t guarantee a full recovery in which the patient will live a normal life after resuscitation. One of the ways health care professionals can anticipate if a patient will survive and go back to normal activity after cardiac arrest is to determine how long the brain is deprived of oxygen. If a person is deprived of oxygen for an extended period of time, recovery of brain activity is unlikely. Currently, it is difficult to know how long a cardiac arrest victim has been oxygen-deprived unless the event has been observed. Often, victims are found unconscious. With time being a critical factor in cardiac arrest, Feinstein Institute Investigator Junhwan Kim and his team were looking for a more immediate indicator of the period the body is deprived of oxygen to better determine if the patient will survive and return to normal function. “Having a method to detect
the onset of cardiac arrest and the length of oxygen deprivation will help physicians make more informed decisions regarding treatment,” said Junhwan Kim, investigator at the Feinstein Institute and lead author of the Biomarker paper. “Patients and their families will benefit as doctors will be able to more immediately assess the severity of the patient’s injuries and have more definitive indicators of survival.” For this study, researchers monitored the change in a lipid metabolite, or molecule, called lysophosphatidylinositol, which increases when there’s a lack of oxygen. Using an animal model, researchers looked at the levels of this molecule in the brain, kidney, liver, heart and blood before and five, 10, 20, 30 and 60 minutes after cardiac arrest. They found that the level of lysophosphatidylinositol increased in these major organs for up to 60 minutes post cardiac arrest. Having proved that lysophosphatidylinositol can indicate how long the body has been deprived of oxygen, Kim and his team are preparing to move into a human study where a blood sample is taken and tested immediately following cardiac arrest and post resuscitation. The results will have a significant impact on treatment and survival of patients with cardiac arrest. “Junhwan Kim and his team are close to determining ways to better administer treatment following cardiac arrest,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute. “This has the potential to improve the lives of the nearly 300,000 Americans who suffer a cardiac arrest each year.”